ArticleThe journal of headache and pain2022

Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients.

Marina de Tommaso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.